This inventor holds 1 USPTO granted patent. Top assignee: Creighton University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Yohan Walter: Innovator in Cancer Radiation Therapy
Introduction
Yohan Walter is a notable inventor based in Kaneohe, HI (US). He has made significant contributions to the field of cancer treatment through his innovative approach to radiation therapy. His work focuses on utilizing biocompatible quantum dots to enhance the effectiveness of radiation therapy for cancerous tumors.
Latest Patents
Yohan Walter holds a patent for a groundbreaking invention titled "Cancer radiation therapy with biocompatible quantum dots for simultaneous dose enhancement and counter-metastasis." This patent describes systems and methods for radiation therapy that utilize biocompatible quantum dots to provide both radiation dose enhancement and resistance to metastasis. The method involves preparing a radiosensitizer fluid containing a plurality of biocompatible quantum dots, introducing this fluid to cancer cells, and subsequently irradiating the cells to promote the generation of reactive oxygen species while inhibiting radiation-induced enhancement of cell migration. He has 1 patent to his name.
Career Highlights
Yohan Walter is affiliated with Creighton University, where he continues to advance his research in cancer therapy. His innovative methods have the potential to significantly improve treatment outcomes for patients suffering from cancer.
Collaborations
Yohan collaborates with talented individuals such as Andrew Edet Ekpenyong and Caleb Thiegs, who contribute to his research efforts and help in the development of his innovative therapies.
Conclusion
Yohan Walter's work in cancer radiation therapy exemplifies the impact of innovation in medical science. His use of biocompatible quantum dots represents a promising advancement in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
